David Brennan to retire as AstraZeneca CEO

Thursday 26 April 2012

David Brennan is to retire as chief executive of AstraZeneca Plc, effective 1 June 2012, the company announced on 26 April. Simon Lowth, the chief financial officer, will act as interim CEO until a permanent successor is found.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom